rcafpfl Profile Banner
RCA Financial Partners Profile
RCA Financial Partners

@rcafpfl

Followers
87
Following
2
Media
6
Statuses
343

A Financial Consulting Firm

St. Petersburg, Florida
Joined May 2021
Don't wanna be here? Send us removal request.
@rcafpfl
RCA Financial Partners
1 year
Exxon 2050 Forecast bucks the trend https://t.co/B2eZ7rl0GV
0
0
0
@rcafpfl
RCA Financial Partners
1 year
0
0
0
@rcafpfl
RCA Financial Partners
1 year
XOM 2024 Energy Outlook forecasts crude demand to remain above 100 MM barrels per day until 2050! This forecast bucks the trend of politically motivated DOE and IEA forecasts predicting a decline.
1
0
0
@rcafpfl
RCA Financial Partners
2 years
Marizyme just received FDA clearance for its flagship product, Duragraft. Duragraft's unique advantages have the potential to establish a new standard of care for the 500,000+ #coronarybypass surgeries performed in the US each year. https://t.co/8lsAcn281T
0
0
0
@rcafpfl
RCA Financial Partners
2 years
Dario is on the leading edge of DTx. With GLP-1, AI and Behavioral Health making headlines, Dario has the integrated solution. Obesity costs the US $173 billion annually, Dario brings data-driven insights to obesity management.
@DarioHealth
DarioHealth™
2 years
We're excited to announce our new program for members taking GLP-1 medications. The program will help members realize the transformative power of these drugs while developing habits that support overall health. To learn more, visit: https://t.co/XcUumeUWHz
0
0
1
@DarioHealth
DarioHealth™
3 years
Our President, Rick Anderson, was featured in a recent article by @modrnhealthcr exploring the current DTX environment and shared his perspective on avenues to success for other DTX companies. To read the article, subscribe to @modrnhealthcr and visit:
Tweet card summary image
modernhealthcare.com
As the digital therapeutics industry deals with a lack of reimbursement pathways, companies like Akili Interactive are taking alternate approaches to growth.
0
2
3
@ErezRaphael
Erez Raphael CEO of Dario Health
3 years
The #DarioHealth team was excited to support the @jedfoundation (JED) last night at their annual gala. #JEDGala2923 empowers teens & young adults by equipping them to build resiliency, life skills, promoting social connectedness & encouraging them to seek & give help when needed
1
4
7
@DarioHealth
DarioHealth™
3 years
@DarioHealth is excited to announce that two new full-suite employer contracts will launch in the second half of 2023. The new accounts selected Dario for the ease of a single, integrated solution. To learn more, visit: https://t.co/iwtiTfYojG
0
3
4
@DrBobGabbay
Dr. Bob
3 years
Obesity treatment options are exploding and ADA’s Scientific Sessions will highlight the expanding universe of incretins- new clinical trials on high dose oral GLP-1 to dual agonists and even triple agonists - CAN’T WAIT! https://t.co/FiViIUOlsY @ADA_DiabetesPro #ADA2023
0
3
12
@sanofi
Sanofi
3 years
As part of our commitment to ensuring comprehensive #diabetes care is accessible in low- and middle-income countries and underserved communities worldwide, we are teaming up with @MoHGhana for a three-year program. Check out this short video about our shared ambition
0
4
13
@DarioHealth
DarioHealth™
3 years
@DarioHealth is excited to announce a new agreement with @MedOneSolutions to deliver Dario's suite of digital health solutions as a complement to their Diabetes Care Path. The launch marks a major milestone achievement with our partner, @SanofiUS. https://t.co/Gh5gAtq8w6
0
2
4
@MarketCurrents
Seeking Alpha Market Currents
3 years
$DRIO - DarioHealth GAAP EPS of -$0.45 beats by $0.05, revenue of $7.07M beats by $0.37M
Tweet card summary image
seekingalpha.com
DarioHealth press release (NASDAQ:DRIO): Q1 GAAP EPS of -$0.45 beats by $0.05.Revenue of $7.07M (-12.3% Y/Y) beats by $0.37M.
0
3
5
@DarioHealth
DarioHealth™
3 years
We were excited for this research to be presented at @ISPORorg on Monday. This is the first of many data points to be released from this important, highly rigorous analysis of digital health. To learn more, visit: https://t.co/W50gcWLodK
0
5
6
@DarioHealth
DarioHealth™
3 years
Our Chief Medical Officer, @drmanejwala, comments on new research released at @ISPORorg by our partner @sanofi. Amazing effort from all who helped propel this research forward. To learn more about the research, read: https://t.co/uHmUv02z3R
0
2
2
@rcafpfl
RCA Financial Partners
3 years
#DarioHealth #diabetes Solution is a #digital #health application for type 2 diabetes mellitus management. It combines a blood #glucose meter and a mobile app, allowing patients to track BG levels in real-time. https://t.co/zYumV6OEGx
ispor.org
OBJECTIVES: Dario Diabetes Solution (DDS) is a digital health application (app) for type 2 diabetes mellitus (T2DM) management. It combines a blood glucose (BG) meter and a mobile app, allowing...
0
0
1
@rcafpfl
RCA Financial Partners
3 years
#DarioHealth announced today that Sanofi #research demonstrates 9.3% reduction in all-cause #healthcare resource utilization rates, including 23.5% decrease in hospitalization. https://t.co/jbvrq0Ck9O
0
0
0
@ErezRaphael
Erez Raphael CEO of Dario Health
3 years
Incredible research from our partners at Sanofi demonstrating the value of Dario in helping to reduce high-cost health care utilization for our clients. Our highly personalized solutions are proven to deliver better outcomes - and now we have clinically r… https://t.co/1u8SeUTZox
linkedin.com
Incredible research from our partners at Sanofi demonstrating the value of Dario in helping to reduce high-cost health care utilization for our clients. Our highly personalized solutions are proven...
1
1
2
@DarioHealth
DarioHealth™
3 years
Studies like this are one of the many reasons we value our partner, @SanofiUS. Congratulations to the research team at Sanofi and our clinical leadership @drmanejwala and Yifat Fundoiano-Hershcovitz on the release of this important data. Learn more: https://t.co/UrPngcQmgT
0
4
5
@DarioHealth
DarioHealth™
3 years
Our President, Rick Anderson, speaks with @modrnhealthcr on the challenges facing prescription digital therapeutics and why there are better options for commercializing proven solutions. To learn more, visit:
0
4
4